As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.


Figure S1. Flow cytometric analysis of mesenchymal stem cells (MSC) at passage 5. MSC were positive for CD13, CD29, CD44, CD73, CD90 and CD105 and negative for CD34, CD45, CD133, CD2, CD31, CD19, CD117, CD11b and HLA-DR.

Table S1. Summary of antibodies used for Western blot and immunohistochemistry

Table S2. Proteins identified in CMCAF, CMMSC and CMrTGF-β1-treated MSC using LC/MS-MS and antibody arrays.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.